INCATE receives Lighthouse Award 2024 from Swiss National Science Foundation

Non-profit organization supports start-ups in the development of urgently needed new antibiotics

02-Jul-2024 - INCATE, the INCubator for Antimicrobial Therapies in Europe, has been honoured with the 2024 Lighthouse Award for outstanding Transfer of Knowledge and Technology by the Swiss National Science Foundation (SNSF). The award ceremony took place on June 27th, in Bern, Switzerland. The SNSF has ...

Investment Plan for Europe: Successful launch of Tech Transfer Fund “KHAN-I”

13-Sep-2019 - Khanu Management GmbH (Khanu), a drug discovery focused fund management team, announces the successful launch of KHAN Technology Transfer Fund I GmbH & Co KG (KHAN-I), based in Dortmund, Germany. The European Investment Fund (EIF, Luxemburg), the Austria Wirtschaftsservice GmbH (Vienna, Austria) ...

For Start-ups and Founders: Inauguration of DESY Innovation Village

The new DESY Innovation Village is the place for start-ups and innovative projects at DESY

26-Feb-2019 - “I Love Innovation” was the fitting motto with which the DESY Innovation Village was officially inaugurated on Valentine’s Day, in the presence of DESY’s Board of Directors and representatives of the federal and local Hamburg governments. It will offer DESY start-ups offices, workshops and ...

Wyatt acquires german FFF manufacturer Superon

Business units to be relocated to California

16-Oct-2018 - Wyatt Technology announced that it has completed the acquisition of Superon GmbH, a manufacturer of Field Flow Fractionation (FFF) systems. Production, research and product development has been transferred to Wyatt’s Santa Barbara, CA headquarters which will enable the company to further enhance ...

Waters acquires DESI-MS technology from Prosolia

Desorption Electrospray Ionization (DESI) imaging gives deeper biological insights

25-Jul-2018 - Waters Corporation, Prosolia, Inc. and the Purdue Research Foundation announced that Waters® acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF. "The acquisition of DESI technology bolsters Waters' ...

SimPath licenses novel ORNL system for enhanced synthetic biology

18-Oct-2017 - SimPath has licensed a novel cloning system developed by the Department of Energy's Oak Ridge National Laboratory that generates and assembles the biological building blocks necessary to synthetically bioengineer new medicines and fuels. Knoxville, Tennessee-based startup SimPath will further ...

Adimab announces technology transfer agreement with Merck & Co.

13-Jan-2016 - Adimab, LLC announced that it has entered into a definitive agreement with Merck, known as MSD outside the United States and Canada, to transfer Adimab’s antibody technology to Merck Research Laboratories for the discovery and optimization of monoclonal and bispecific therapeutic antibody ...

CHEMIE.DE gives technological support for the launch of a food and beverages internet portal

The new B2B web portal yumda.de builds on the proven technology of Europe's leading chemistry portal

02-Dec-2013 - To launch their B2B portal for the food and beverages industries on the basis of a successful concept straight from the beginning, yumda.de has trusted in the extensive experience of CHEMIE.DE Information Service GmbH. The Berlin-based online information provider has technologically implemented ...

DPZ Signs License Agreement with Biogen Idec

22-Feb-2011 - The German Primate Center (DPZ) and its technology transfer partner Ascenion announced the signing of a license agreement providing Biogen Idec with exclusive, worldwide rights to a patent portfolio directed to a recombinant virus-like particle (VLP) containing VP1 protein for the detection of ...

Biotie and Roche conclude research and option agreement for SSAO inhibitors

02-Nov-2010 - Biotie announced that its research and option agreement with Roche for the development of small molecule inhibitors of SSAO (semicarbazide-sensitive amine oxidase) has been terminated by mutual agreement. Timo Veromaa, Chief Executive Officer of Biotie commented, "We have made significant ...